DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Fanola CL, Ruff CT, Murphy SA. et al.
Efficacy and safety of edoxaban in patients with active malignancy and atrial fibrillation: analysis of the engage AF-TIMI 48 trial.
J Am Heart Assoc 2018;
7 (16) e008987
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.